| Authors: |
Serra-Bellver P; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address: p.serra@nhs.net., Versluis JM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Oberoi HK; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Zhou C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, United Kingdom., Slattery TD; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Khan Y; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Patrinely JR; Department of Medical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Pires da Silva I; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Westmead and Blacktown Hospital, Sydney, Australia., Martínez-Vila C; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Cook N; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom., Graham DM; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom., Carlino MS; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Westmead and Blacktown Hospital, Sydney, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia., Arance AM; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Johnson DB; Department of Medical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Long GV; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia., Pickering L; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Larkin JMG; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Blank CU; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lorigan P; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom. |
